Neuropathy Associated with the Monoclonal Gammopathies

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 2255-2276

  Kyle, Robert A ^a   Dyck, Peter J ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646679566     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50103-4     Document Type: Chapter

References (162)

1. Axelsson U., Bachmann R., Hallen J. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med. Scand. 1966, 179:235.
2. Baba H., Miyatani N., Sato S., et al. Antibody to glycolipid in a patient with IgM paraproteinemia and polyradiculoneuropathy. Acta Neurol. Scand. 1985, 72:218.
3. Bailey R.O., Ritaccio A.L., Bishop M.B., Wu A.Y. Benign monoclonal IgAK gammopathy associated with polyneuropathy and dysautonomia. Acta Neurol. Scand. 1986, 73:574.
4. Baldini L., Guffanti A., Cesana B.M., et al. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood 1996, 87:912.
5. Baldini L., Nobile-Orazio E., Guffanti A, et al. Peripheral neuropathy in IgM monoclonal gammopathy and Waldenström's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component. Am. J. Hematol. 1994, 45:25.
6. Besinger U.A., Toyka K.V., Anzil A.P., et al. Myeloma neuropathy: passive transfer from man to mouse. Science 1981, 213:1027.
7. Bleasel A.F., Hawke S.H., Pollard J.D., McLeod J.G. IgG monoclonal paraproteinaemia and peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 1993, 56:52.
8. Bollensen E., Steck A.J., Schachner M. Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology 1988, 38:1266.
9. Borges L.F., Busis N.A. Intraneuronal accumulation of myeloma proteins. Arch. Neurol. 1985, 42:690.
10. Bosch E.P., Ansbacher L.E., Goeken J.A., Cancilla P.A. Peripheral neuropathy associated with monoclonal gammopathy: studies of intraneural injections of monoclonal immunoglobulin sera. J. Neuropathol. Exp. Neurol. 1982, 41:446.
11. Brouet J.C., Dellagi K., Gendron M.C., et al. Expression of a public idiotype by human monoclonal IgM directed to myelin-associated glycoprotein and characterization of the variability subgroup of their heavy and light chains. J. Exp. Med. 1989, 170:1551.
12. Brudon F., Bady B., Chauplannaz G., et al. Clinical amyotrophic lateral sclerosis syndromes in gammopathies: clinical, electrophysiologic and histoimmunologic aspects [in French]. Rev. Electroencephalogr. Neurophysiol. Clin. 1986, 15:369.
13. Busis N.A., Halperin J.J., Stefansson K., et al. Peripheral neuropathy, high serum IgM, and paraproteinemia in mother and son. Neurology 1985, 35:679.
14. Carpo M., Nobile-Orazio E., Meucci N., et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann. Neurol. 1996, 39:539.
15. Cesana C., Klersy C., Barbarano L., et al. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J. Clin. Oncol. 2002, 20:1625.
16. Chassande B., Leger J.M., Younes-Chennoufi A.B., et al. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve 1998, 21:55.
17. Cocito D., Isoardo G., Ciaramitaro P., et al. Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody. Muscle Nerve 2001, 24:1278.
18. Dalakas M.C., Flaum M.A., Rick M., et al. Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies. Neurology 1983, 33:1406.
19. Dalakas M.C., Quarles R.H., Farrer R.G., et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann. Neurol. 1996, 40:792.
20. D'Amico G., Colasanti G., Ferrario F., et al. Renal involvement in essential mixed cryoglobulinemia: a peculiar type of immune-mediated renal disease. Adv. Nephrol. Necker Hosp. 1988, 17:219.
21. Dammacco F., Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin. Exp. Immunol. 1992, 87:352.
22. Davidson S. Solitary myeloma with peripheral polyneuropathy-recovery after treatment. Calif. Med. 1972, 116:68.
23. Davis L.E., Drachman D.B. Myeloma neuropathy: successful treatment of two patients and review of cases. Arch. Neurol. 1972, 27:507.
24. Davison C., Balser B.H. Myeloma and its neural complications. Arch. Surg. 1937, 35:913.
25. Dayan A.D., Stokes M.I. Peripheral neuropathy and experimental myeloma in the mouse. Nat. New Biol. 1972, 236:117.
26. Delauche M.C., Clauvel J.P., Seligmann M. Peripheral neuropathy and plasma cell neoplasias: a report of 10 cases. Br. J. Haematol. 1981, 48:383.
27. Dellagi K., Dupouey P., Brouet J.C., et al. Waldenström's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood 1983, 62:280.
28. Desai J., Swash M. IgM paraproteinemia in a patient with primary lateral sclerosis. Neuromuscul. Disord. 1999, 9:38.
29. Dhib-Jalbut S., Liwnicz B.H. Binding of serum IgA of multiple myeloma to normal peripheral nerve. Acta Neurol. Scand. 1986, 73:381.
30. Dispenzieri A., Gertz M.A., Therneau T.M., Kyle R.A. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin. Proc. 2001, 76:476.
31. Donaghy M., Duchen L.W. Sera from patients with motor neuron disease and associated paraproteinaemia fail to inhibit experimentally induced sprouting of motor nerve terminals. J. Neurol. Neurosurg. Psychiatry 1986, 49:817.
32. Dyck P.J., Low P.A., Windebank A.J., et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 1991, 325:1482.
33. Eurelings M., Ang C.W., Notermans N.C., et al. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 2001, 57:1909.
34. Eurelings M., Moons K.G., Notermans N.C., et al. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide. Neurology 2001, 56:228.
35. Eurelings M., Notermans N.C., Franssen H., et al. MRI of the brachial plexus in polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 2001, 24:1312.
36. Eurelings M., Notermans N.C., Van de Donk N.W., Lokhorst H.M. Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 2001, 24:1295.
37. Eurelings M., Notermans N.C., Wokke J.H., et al. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy. Acta Neuropathol. (Berl.) 2002, 103:107.
38. Faed J.M., Day B., Pollock M., et al. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Neurology 1989, 39:422.
39. Forssman O., Bjorkman G., Hollender A., Englund N.E. IgM-producing lymphocytes in peripheral nerve in a patient with benign monoclonal gammopathy. Scand. J. Haematol. 1973, 11:332.
40. Frail D.E., Edwards A.M., Braun P.E. Molecular characteristics of the epitope in myelin-associated glycoprotein that is recognized by a monoclonal IgM in human neuropathy patients. Mol. Immunol. 1984, 21:721.
41. Frayne J., Stark R.J. Peripheral neuropathy with gammopathy responding to plasmapheresis. Clin. Exp. Neurol. 1985, 21:195.
42. Freddo L., Ariga T., Saito M., et al. The neuropathy of plasma cell dyscrasia: binding of IgM M-proteins to peripheral nerve glycolipids. Neurology 1985, 35:1420.
43. Freddo L., Sherman W.H., Latov N. Glycosaminoglycan antigens in peripheral nerve: studies with antibodies from a patient with neuropathy and monoclonal gammopathy. J. Neuroimmunol. 1986, 12:57.
44. Galassi G., Nemni R. Sensory action potentials and biopsy of the sural nerve in the neuropathy of nonmalignant IgMK plasma cell dyscrasia. Eur. Neurol. 1986, 25:1.
45. Gorevic P.D., Kassab H.J., Levo Y., et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am. J. Med. 1980, 69:287.
46. Gorson K.C., Allam G., Ropper A.H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997, 48:321.
47. Gosselin S., Kyle R.A., Dyck P.J. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann. Neurol. 1991, 30:54.
48. Green A.R., Whittaker J.A. IgM paraprotein reactive with muscle antigens associated with autonomic and peripheral neuropathy. Br. J. Haematol. 1989, 72:108.
49. Haas D.C., Tatum A.H. Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia. Ann. Neurol. 1988, 23:394.
50. Hafler D.A., Johnson D., Kelly J.J., et al. Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics. Neurology 1986, 36:75.
51. Hällen J. Frequency of "abnormal" serum globulins (M-components) in the aged. Acta Med. Scand. 1963, 173:737.
52. Harbs H., Arfmann M., Frick E., et al. Reactivity of sera and isolated monoclonal IgM from patients with Waldenström's macroglobulinaemia with peripheral nerve myelin. J. Neurol. 1985, 232:43.
53. Hays A.P., Latov N., Takatsu M., Sherman W.H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987, 37:242.
54. Ilyas A.A., Li S.C., Chou D.K., et al. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J. Biol. Chem. 1988, 263:4369.
55. Ilyas A.A., Quarles R.H., Dalakas M.C., et al. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann. Neurol. 1985, 18:655.
56. Ilyas A.A., Quarles R.H., MacIntosh T.D., et al. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:1225.
57. Ilyas A.A., Willison H.J., Dalakas M.C., et al. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J. Neurochem. 1988, 51:851.
58. Isobe T., Osserman E.F. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann. N. Y. Acad. Sci. 1971, 190:507.
59. Jauberteau M.O., Younes-Chennoufi B., Rigaud M., Baumann N. IgM gammopathy and polyneuropathy react with an antigenic glycolipid present in human central nervous system. Neurosci. Lett. 1989, 97:181.
60. Johansen P., Leegaard O.F. Peripheral neuropathy and paraproteinemia: an immunohistochemical and sero-logic study. Clin. Neuropathol. 1985, 4:99.
61. Jønsson V., Schroder H.D., Staehelin Jensen T., et al. Autoimmunity related to IgM monoclonal gammopathy of undetermined significance: peripheral neuropathy and connective tissue sensibilization caused by IgM M-proteins. Acta Med. Scand. 1988, 223:255.
62. Kahn S.N., Riches P.G., Kohn J. Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J. Clin. Pathol. 1980, 33:617.
63. Kelly J.J., Adelman L.S., Berkman E., Bhan I. Polyneuropathies associated with IgM monoclonal gammopathies. Arch. Neurol. 1988, 45:1355.
64. Kelly J.J. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve 1983, 6:504.
65. Kelly J.J., Kyle R.A., Latov N. Polyneuropathies Associated with Plasma Cell Dyscrasias 1987, Martinus Nijhoff, Boston.
66. Kelly J.J., Kyle R.A., O'Brien P.C., Dyck P.J. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981, 31:1480.
67. Keren D.F., Alexanian R., Goeken J.A., et al. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. Arch. Pathol. Lab. Med. 1999, 123:106.
68. Krol-v Straaten M.J., Ackerstaff R.G., De Maat C.E Peripheral polyneuropathy and monoclonal gammopathy of undetermined significance. J. Neurol. Neurosurg. Psychiatry 1985, 48:706.
69. Kusunoki S., Kohriyama T., Pachner A.R., et al. Neuropathy and IgM paraproteinemia: differential binding of IgM M-proteins to peripheral nerve glycolipids. Neurology 1987, 37:1795.
70. Kusunoki S., Shimizu T., Matsumura K., et al. Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides. J. Neuroimmunol. 1989, 21:177.
71. Kvarnström M., Sidorova E., Nilsson J., et al. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS). Clin. Exp. Immunol. 2002, 127:255.
72. Kyle R.A. Sequence of testing for monoclonal gammopathies. Arch. Pathol. Lab. Med. 1999, 123:114.
73. Kyle R.A., Finkelstein S., Elveback L.R., Kurland L.T. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 1972, 40:719.
74. Kyle R.A., Garton J.P. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin. Proc. 1987, 62:719.
75. Kyle R.A., Gertz M.A., Witzig T.E., et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin. Proc. 2003, 78:21.
76. Kyle R.A., Greipp P.A. Plasma cell dyscrasias: current status. Crit. Rev. Oncol. Hematol. 1988, 8:93.
77. Kyle R.A., Katzmann J.A., Lust J.A., Dispenzieri A. Immunochemical characterization of immunoglobulins. Manual of Clinical Laboratory Immunology 2002, 71. ASM Press, Washington, DC. N.R. Rose, R.G. Hamilton, B. Detrick (Eds.).
78. Kyle R.A., Robinson R.A., Katzmann J.A. The clinical aspects of biclonal gammopathies: review of 57 cases. Am. J. Med. 1981, 71:999.
79. Kyle R.A., Therneau T.M., Rajkumar S.V., et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 2002, 346:564.
80. Lach B., Rippstein P., Atack D., et al. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinating neuropathy. Acta Neuropathol. 1993, 85:298.
81. Latov N. Plasma cell dyscrasia and motor neuron disease. Adv. Neurol. 1982, 36:273.
82. Latov N., Hays A.P., Sherman W.H. Peripheral neuropathy and anti-MAG antibodies. Crit. Rev. Neurobiol. 1988, 3:301.
83. Latov N., Sherman W.H., Nemni R., et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N. Engl. J. Med. 1980, 303:618.
84. Lawlor M.W., Richards M.P., Fisher M.A., Stubbs E.B. Sensory nerve conduction deficit in experimental monoclonal gammopathy of undetermined significance (MGUS) neuropathy. Muscle Nerve 2001, 24:809.
85. Leibowitz S., Gregson N.A., Kennedy M., Kahn S.N. IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy. J. Neurol. Sci. 1983, 59:153.
86. Letendre L., Kyle R.A. Monoclonal cryoglobulinemia with high thermal insolubility. Mayo Clin. Proc. 1982, 57:629.
87. Levine T.D., Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rit-uximab. Neurology 1999, 52:1701.
88. Lieberman F., Marton L.S., Stefansson K. Pattern of reactivity of IgM from the sera of eight patients with IgM monoclonal gammopathy and neuropathy with components of neural tissues: evidence for interaction with more than one epitope. Acta Neuropathol. 1985, 68:196.
89. Maisonobe T., Chassande B., Verin M., et al. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J. Neurol. Neurosurg. Psychiatry 1996, 61:36.
90. Manschot S.M., Notermans N.C., van den Berg L.H., et al. Three families with polyneuropathy associated with monoclonal gammopathy. Arch. Neurol. 2000, 57:740.
91. Mariette X., Chastang C., Clavelou P., for the IgM-associated Polyneuropathy Study Group, et al. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. J. Neurol. Neurosurg. Psychiatry 1997, 63:28.
92. Mata M., Kahn S.N., Fink D.J. A direct electron microscopic immunocytochemical study of IgM paraproteinemic neuropathy. Arch. Neurol. 1988, 45:693.
93. Mazzi G., Raineri A., Zucco M., et al. Plasma-exchange in chronic peripheral neurological disorders. Int. J. Artif. Organs 1999, 22:40.
94. Meier C., Vandevelde M., Steck A., Zurbriggen A. Demyelinating polyneuropathy associated with monoclonal IgM-paraproteinaemia: histological, ultrastructural and immunocytochemical studies. J. Neurol. Sci. 1984, 63:353.
95. Merkies I.S., Schmitz P.I., van der Meche F.G., et al. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002, 59:84.
96. Merlini, G., Rutigliano, L., Masnaghetti, S., et al.: Neuromuscular disorders associated with monoclonal immunoglobulins. In Abstracts of the International Conference on Multiple Myeloma: Biology, Pathophysiology, Prognosis, and Treatment, Bologna, Italy, June 19-22, p. 215, 1989.
97. Meucci N., Baldini L., Cappellari A., et al. Anti-myelin-associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy. Ann. Neurol. 1999, 46:119.
98. Micouin C., Seigneurin J.M., Renversez J.C., et al. Monoclonal IgM with anti-muscle tissue activity in a patient with Waldenström's macroglobulinemia: secretion of identical immunoglobulin by the established lymphoid cell line. Clin. Exp. Immunol. 1984, 58:677.
99. Monaco S., Bonetti B., Ferrari S., et al. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N. Engl. J. Med. 1990, 322:649.
100. Montagnino G. Reappraisal of the clinical expression of mixed cryoglobulinemia. Springer Semin. Immunopathol. 1988, 10:1.
101. Mygland A., Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur. J. Neurol. 2001, 8:157.
102. Nardelli E., Pizzighella S., Tridente G., Rizzuto N. Peripheral neuropathy associated with immunoglobulin disorders: an immunological and ultrastructural study. Acta Neuropathol. (Berl.) 1980, 258. Suppl. VII.
103. Nemni R., Fazio R., Corbo M., et al. Peripheral neuropathy associated with experimental plasma cell neoplasm in the mouse. J. Neurol. Sci. 1987, 77:321.
104. Nemni R., Galassi G., Latov N., et al. Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study. Ann. Neurol. 1983, 14:43.
105. Nobile-Orazio E., Barbieri S., Baldini L., et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol. Scand. 1992, 85:383.
106. Nobile-Orazio E., Carpo M. Neuropathy and monoclonal gammopathy. Curr. Opin. Neurol. 2001, 14:615.
107. Nobile-Orazio E., Francomano E., Daverio R., et al. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. Ann. Neurol. 1989, 26:543.
108. Nobile-Orazio E., Hays A.P., Latov N., et al. Specificity of mouse and human monoclonal antibodies to myelin-associated glycoprotein. Neurology 1984, 34:1336.
109. Nobile-Orazio E., Vietorisz T., Messito M.J., et al. Anti-MAG IgM antibodies in patients with neuropathy and IgM M proteins: detection by ELISA. Neurology 1983, 33:939.
110. Notermans N.C., Vermeulen M., Lokhorst H.M., et al. Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy. J. Neurol. 1997, 244:462.
111. Oksenhendler E., Chevret S., Leger J.M., for the IgM-associated Polyneuropathy Study Group, et al. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J. Neurol. Neurosurg. Psychiatry 1995, 59:243.
112. Osby E., Noring L., Hast R., et al. Benign monoclonal gammopathy and peripheral neuropathy. Br. J. Haematol. 1982, 51:531.
113. O'Shannessy D.J., Ilyas A.A., Dalakas M.C., et al. Specificity of human IgM monoclonal antibodies from patients with peripheral neuropathy. J. Neuroimmunol. 1986, 11:131.
114. Patten B.M. Neuropathy and motor neuron syndromes associated with plasma cell disease. Acta Neurol. Scand. 1984, 70:47.
115. Pellegrini G., Scarlato G., Moggio M., et al. Sensorimotor polyneuropathy in light chain multiple myeloma. Acta Neuropathol. (Berl.) 1980, 255. Suppl. VII.
116. Petratos S., Turnbull V.J., Papadopoulos R., et al. High-titre IgM anti-sulfatide antibodies in individuals with IgM paraproteinaemia and associated peripheral neuropathy. Immunol. Cell Biol. 2000, 78:124.
117. Pollard J.D., McLeod J.G., Feeney D. Peripheral neuropathy in IgM kappa paraproteinaemia: clinical and ultrastructural studies in two patients. Clin. Exp. Neurol. 1985, 21:41.
118. Poloni M., Rocchelli B., Pinelli P., Scelsi R. Neuromuscular diseases associated with benign monoclonal gammopathy: study of CSF and serum proteins by isoelectric focusing. Acta Neurol. Scand. 1982, 65:154.
119. Powell H.C., Rodriguez M., Hughes R.A. Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann. Neurol. 1984, 15:386.
120. Quarles R.H., Weiss M.D. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 1999, 22:800.
121. Read D., Warlow C. Peripheral neuropathy and solitary plasmacytoma. J. Neurol. Neurosurg. Psychiatry 1978, 41:177.
122. Read D.J., Vanhegan R.I., Matthews W.B. Peripheral neuropathy and benign IgG paraproteinaemia. J. Neurol. Neurosurg. Psychiatry 1978, 41:215.
123. Rebai T., Mhiri C., Heine P., et al. Focal myelin thickenings in a peripheral neuropathy associated with IgM monoclonal gammopathy. Acta Neuropathol. 1989, 79:226.
124. Riches P.G., Sheldon J., Smith A.M., Hobbs J.R. Overestimation of monoclonal immunoglobulin by immuno-chemical methods. Ann. Clin. Biochem. 1991, 28:253.
125. Rowland L.P., Defendini R., Sherman W., et al. Macroglobulinemia with peripheral neuropathy simulating motor neuron disease. Ann. Neurol. 1982, 11:532.
126. Saito T., Sherman W.H., Latov N. Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy. J. Immunol. 1983, 130:2496.
127. Saleun J.P., Vicariot M., Deroff P., Morin J.F. Monoclonal gammopathies in the adult population of Finistère, France. J. Clin. Pathol. 1982, 35:63.
128. Saverino A., Solaro C., Capello E., et al. Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin. Mov. Disord. 2001, 16:967.
129. Seligmann, M., Brouet, J.-C., and Dellagi, K. Antibody activities of human monoclonal gammopathies with special emphasis on monoclonal IgM in patients with peripheral neuropathy Proceedings of the EURAGE Symposium on Monoclonal Gammopathies: Clinical Significance and Basic Mechanisms, Brussels, September 19-20, p. 49, 1985.
130. Sewell H.F., Matthews J.B., Gooch E., et al. Autoantibody to nerve tissue in a patient with a peripheral neuropathy and an IgG paraprotein. J. Clin. Pathol. 1981, 34:1163.
131. Sherman W.H., Latov N., Hays A.P., et al. Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis. Neurology 1983, 33:192.
132. Sherman W.H., Latov N., Lange D., et al. Fludarabine for IgM antibody-mediated neuropathies [abstract]. Ann. Neurol. 1994, 36:326.
133. Sherman W.H., Olarte M.R., McKiernan G., et al. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J. Neurol. Neurosurg. Psychiatry 1984, 47:813.
134. Shy M.E., Vietorisz T., Nobile-Orazio E., Latov N. Specificity of human IgM M-proteins that bind to myelin-associated glycoprotein: peptide mapping, deglycosylation, and competitive binding studies. J. Immunol. 1984, 133:2509.
135. Silverstein A., Doniger D.E. Neurologic complications of myelomatosis. Arch. Neurol. 1963, 9:102.
136. Simmons Z. Paraproteinemia and neuropathy. Curr. Opin. Neurol. 1999, 12:589.
137. Simmons Z., Albers J.W., Bromberg M.B., Feldman E.L. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 1993, 43:2202.
138. Simmons Z., Albers J.W., Bromberg M.B., Feldman E.L. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995, 118:359.
139. Simmons Z., Bromberg M.B., Feldman E.L., Blaivas M. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Muscle Nerve 1993, 16:77.
140. Simovic D., Gorson K.C., Ropper A.H. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy. Acta Neurol. Scand. 1998, 97:194.
141. Smith I.S., Kahn S.N., Lacey B.W., et al. Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain 1983, 106:169.
142. Smith T., Sherman W., Olarte M.R., Lovelace R.E. Peripheral neuropathy associated with plasma cell dyscrasia: a clinical and electrophysiological follow-up study. Acta Neurol. Scand. 1987, 75:244.
143. Steck A.J., Murray N., Dellagi K., et al. Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann. Neurol. 1987, 22:764.
144. Steck A.J., Murray N., Meier C., et al. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology 1983, 33:19.
145. Stefansson K., Marton L., Antel J.P., et al. Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol. 1983, 59:255.
146. Suarez G.A., Kelly J.J. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993, 43:1304.
147. Toepfer M., Schroeder M., Muller-Felber W., et al. Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption. Clin. Nephrol. 2000, 53:404.
148. Valli G., De Vecchi A., Gaddi L., et al. Peripheral nervous system involvement in essential cryoglobulinemia and nephropathy. Clin. Exp. Rheumatol. 1989, 7:479.
149. Victor M., Banker B.Q., Adams R.D. The neuropathy of multiple myeloma. J. Neurol. Neurosurg. Psychiatry. 1958, 21:73.
150. Vital A. Paraproteinemic neuropathies. Brain Pathol. 2001, 11:399.
151. Vital A., Vital C., Julien J., et al. Polyneuropathy associated with IgM monoclonal gammopathy: immunological and pathological study in 31 patients. Acta Neuropathol. 1989, 79:160.
152. Vladutiu A.O. Prevalence of M-proteins in serum of hospitalized patients: physician's response to finding M-proteins in serum protein electrophoresis. Ann. Clin. Lab. Sci. 1987, 17:157.
153. Vrethem M., Cruz M., Wen-Xin H., et al. Clinical, neuro-physiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies. J. Neurol. Sci. 1993, 114:193.
154. Waldenström J. Abnormal proteins in myeloma. Adv. Intern. Med. 1952, 5:398.
155. Waldenström J. Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect. 1961, 56:211.
156. Walsh J.C. The neuropathy of multiple myeloma: an electrophysiological and histological study. Arch. Neurol. 1971, 25:404.
157. Whicher J.T., Wallage M., Fifield R. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins. Clin. Chem. 1987, 33:1771.
158. Wilson H.C., Lunn M.P., Schey S., Hughes R.A. Successful treatment of IgM paraproteinaemic neuropathy with fludarabine. J. Neurol. Neurosurg. Psychiatry 1999, 66:575.
159. Wilson J.R., Stittsworth J.D., Fisher M.A. Electrodiagnostic patterns in MGUS neuropathy. Electromyogr. Clin. Neurophysiol. 2001, 41:409.
160. Wolfe G.I., Nations S.P. Guide to autoantibody testing in peripheral neuropathies. Neurologist 2001, 7:195.
161. Yee W.C., Hahn A.F., Hearn S.A., Rupar A.R. Neuropathy in IgM lambda paraproteinemia: immunoreactivity to neural proteins and chondroitin sulfate. Acta Neuropathol. 1989, 78:57.
162. Younger D.S., Rowland L.P., Latov N., et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990, 40:595.